Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke..
Blood Coagul Fibrinolysis. 27(2), 185-9.
(2016). The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia..
Curr Pharm Des. 23(10), 1495-1499.
(2017). Nonalcoholic fatty liver disease and statins..
Metabolism. 64(10), 1215-23.
(2015). Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance..
Front Biosci (Landmark Ed). 14, 237-62.
(2009). Predictive value of the ankle brachial index in patients with acute ischemic stroke..
Vasa. 43(1), 55-61.
(2014). Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome..
Front Endocrinol (Lausanne). 9, 149.
(2018). Impaired kidney function evaluated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is associated with more severe acute ischemic stroke..
Vasc Med. 22(5), 432-434.
(2017). Unresolved issues in lipid-lowering treatment..
Panminerva Med. 58(2), 191-5.
(2016). Prognostic significance of major lipids in patients with acute ischemic stroke..
Metab Brain Dis. 32(2), 395-400.
(2017). Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation..
J Thromb Thrombolysis. 41(2), 336-42.
(2016). Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?.
Expert Opin Ther Targets. 12(7), 809-20.
(2008). Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus..
Rheumatol Int. 37(2), 293-298.
(2017). Dyslipidemia as a risk factor for ischemic stroke..
Curr Top Med Chem. 9(14), 1291-7.
(2009). Prevalence of resistant hypertension in 1810 patients followed up in a specialized outpatient clinic and its association with the metabolic syndrome..
Blood Press. 22(5), 307-11.
(2013). Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome..
World J Hepatol. 5(11), 621-6.
(2013). Effects of different classes of antihypertensive agents on the outcome of acute ischemic stroke..
J Clin Hypertens (Greenwich). 17(4), 275-80.
(2015). Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options..
Curr Vasc Pharmacol. 10(2), 162-72.
(2012). Lipoprotein a: where are we now?.
Curr Opin Cardiol. 24(4), 351-7.
(2009). Increased augmentation index is paradoxically associated with lower in-hospital mortality in patients with acute ischemic stroke..
Atherosclerosis. 236(1), 150-3.
(2014). Left ventricular hypertrophy assessed by electrocardiogram is associated with more severe stroke and with higher in-hospital mortality in patients with acute ischemic stroke..
Atherosclerosis. 274, 206-211.
(2018). The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification..
Curr Opin Cardiol. 25(4), 394-8.
(2010). Clinical controversies in lipid management..
Panminerva Med. 57(2), 65-70.
(2015). Liver iron content determination by magnetic resonance imaging..
World J Gastroenterol. 16(13), 1587-97.
(2010). Familial burden of hypertension and its effect on blood pressure levels, insulin resistance, and intracellular ions in Greek offspring..
J Am Soc Hypertens. 3(2), 141-9.
(2009). EEG Window Length Evaluation for the Detection of Alzheimer’s Disease over Different Brain Regions.
Brain Sciences. 9121815291(4), 81.
(2019).